AndrewZlozaMD

PubMed

• 16 citations
  Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer
  Terese Geraghty, Anugraha Rajagopalan, Rabail Aslam, Alexander Pohlman, Ishwarya Venkatesh, Andrew Zloza, David Cimbaluk, David G. DeNardo, Vineet Gupta> ;Frontiers in Oncology. 2020 May 21
• 119 citations
  Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
  Jenna H. Newman, C. Brent Chesson, Nora L. Herzog, Praveen K. Bommareddy, Salvatore M. Aspromonte, Russell J. Pepe, Ricardo Estupinian, Mones M. Aboelatta, Stuti Buddh...> ;Proceedings of the National Academy of Sciences of the United States of America. 2020 Jan 14
• 11 citations
  High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma.
  Ann W. Silk, Howard L. Kaufman, Brendan D. Curti, Janice M. Mehnert, Kim Margolin, David F. McDermott, Joseph I. Clark, Jenna H. Newman, Praveen K. Bommareddy, Lisa K....> ;Frontiers in Oncology. 2020 Jan 10
• 5 citations
  Editorial: Tumor Microenvironment and Resistance to Current Therapies.
  Ahmed Lasfar, Murugabaskar Balan, Karine A. Cohen-Solal, Andrew Zloza> ;Frontiers in Oncology. 2019 Nov 14
• 42 citations
  Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.
  Mark N. Stein, Jyoti Malhotra, Rohinton Tarapore, Usha Malhotra, Ann W. Silk, Nancy Chan, Lorna Rodriguez, Joseph Aisner, Robert Aiken, Tina M. Mayer, Bruce G. Haffty,...> ;Journal for Immunotherapy of Cancer. 2019 May 22
• 75 citations
  Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma.
  Praveen K. Bommareddy, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman> ;Oncoimmunology. 2019 Apr 7
• 10 citations
  Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment.
  Jorge E. Romaguera, Hun J. Lee, Rohinton Tarapore, Varun V. Prabhu, Joshua E. Allen, Lee Schalop, Andrew Zloza, Chi Young Ok, Evita Sadimin, Jason M. Schenkel, Maria B...> ;British Journal of Haematology. 2019 Apr 1
• 23 citations
  Interferon Lambda: Toward a Dual Role in Cancer.
  Ahmed Lasfar, Andrew Zloza, Ann W. Silk, Leonard Y. Lee, Karine A. Cohen-Solal> ;Journal of Interferon & Cytokine Research. 2019 Jan 10
• 5 citations
  Immunobiochemical Reconstruction of Influenza Lung Infection-Melanoma Skin Cancer Interactions.
  Evgeni V. Nikolaev, Andrew Zloza, Eduardo D. Sontag> ;Frontiers in Immunology. 2019 Jan 28
• 1 citations
  Double-Humanized Mouse Model to Study Bone Morphogenetic Protein (BMP) Signaling in Tumor Xenografts
  Jenna H. Newman, Rachel NeMoyer, Andrew Zloza, John Langenfeld> ;Methods in Molecular Biology. 2019 Jan 1
• 88 citations
  MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation.
  Praveen K. Bommareddy, Salvatore M. Aspromonte, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman> ;Science Translational Medicine. 2018 Dec 12
• 48 citations
  Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment
  Jessica Wagner, C. Leah B. Kline, Lanlan Zhou, Kerry S. Campbell, Alexander W. MacFarlane, Anthony J. Olszanski, Kathy Q. Cai, Harvey Hensley, Eric A. Ross, Marie D. R...> ;The Journal of Clinical Investigation. 2018 Jun 1
• 13 citations
  Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
  Jenna H. Newman, David Augeri, Rachel NeMoyer, Jyoti Malhotra, Elaine Langenfeld, Charles B. Chesson, Natalie S. Dobias, Michael J. Lee, Saeed Tarabichi, Sachin R. Jha...> ;Oncogene. 2018 Apr 6
• 30 citations
  A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
  Janice M. Mehnert, Ann W. Silk, Jonathan H. Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M. Schenkel, Evita Sadimin, Michael P. Kane, Hongxia Lin, Weichung ...> ;Pigment Cell & Melanoma Research. 2018 Jul 1
• 10 citations
  Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancer
  Andrew Zloza> ;Journal for Immunotherapy of Cancer. 2018 Jan 8
• 14 citations
  Supramolecular Peptide Nanofibers Engage Mechanisms of Autophagy in Antigen-Presenting Cells
  Jai S. Rudra, Arshad Khan, Tara M. Clover, Janice J. Endsley, Andrew Zloza, Jin Wang, Chinnaswamy Jagannath> ;ACS Omega. 2017 Dec 20
• 24 citations
  Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.
  Charles B. Chesson, Andrew Zloza> ;Nanomedicine. 2017 Nov 3
• 8 citations
  Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: A report from the associated programs of...
  Andrew Zloza, A. Karolina Palucka, Lisa M. Coussens, Philip Gotwals, Mark B. Headley, Elizabeth M. Jaffee, Amanda W. Lund, Arlene H. Sharpe, Mario Sznol, Derek A. Wain...> ;Journal for Immunotherapy of Cancer. 2017 Sep 19
• 93 citations
  Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.
  Sachin R. Jhawar, Aditya Thandoni, Praveen K. Bommareddy, Suemair Hassan, Frederick J. Kohlhapp, Sharad Goyal, Jason M. Schenkel, Ann W. Silk, Andrew Zloza> ;Frontiers in Oncology. 2017 Sep 11
• 100 citations
  First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors
  Mark N. Stein, Joseph R. Bertino, Howard L. Kaufman, Tina M. Mayer, Rebecca A. Moss, Ann W. Silk, Nancy Chan, Jyoti Malhotra, Loma Rodriguez, Joseph Aisner, Robert Aik...> ;Clinical Cancer Research. 2017 Aug 1
• 75 citations
  CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus
  Mohd Hafeez Faridi, Samia Q. Khan, Wenpu Zhao, Ha Won Lee, Mehmet M. Altintas, Kun Zhang, Vinay Kumar, Andrew Armstrong, Carmelo Carmona-Rivera, Jessica M. Dorschner, ...> ;The Journal of Clinical Investigation. 2017 Apr 3
• 13 citations
  Infection: a Cause of and Cure for Cancer
  Jenna H. Newman, Andrew Zloza> ;Current Pharmacology Reports. 2017 Oct 5
• 108 citations
  Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
  Eunsil Hahm, Changli Wei, Isabel Fernandez, Jing Li, Nicholas J. Tardi, Melissa Tracy, Shikha Wadhwani, Cao Yanxia, Vasil Peev, Andrew Zloza, Jevgenijs Lusciks, Salim ...> ;Nature Medicine. 2017 Jan 1
• 20 citations
  IFN-λ: A New Inducer of Local Immunity against Cancer and Infections
  Ahmed Lasfar, Andrew Zloza, Andrew N. de la Torre, Karine A. Cohen-Solal> ;Frontiers in Immunology. 2016 Dec 15
• 7 citations
  Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma
  Andrew Zloza, Neal D. Dharmadhikari, Erica J. Huelsmann, Joseph R. Broucek, Tasha Hughes, Frederick J. Kohlhapp, Howard L. Kaufman> ;Cancer Immunology, Immunotherapy. 2017 Jan 1
• Join now to see all